Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

Human Microbiome Market Share

Report ID: GMI6538
   |
Published Date: October 2024
 | 
Report Format: PDF

Download free sample

Human Microbiome Market Share

These companies are at the forefront of developing microbiome-based drugs and therapies, focusing on addressing unmet medical needs in areas such as infectious diseases, gastrointestinal disorders, and metabolic conditions. Strategic partnerships, collaborations with academic institutions, and investments in research and development are key strategies employed by industry leaders to enhance their market presence and accelerate the commercialization of microbiome-based therapies.
 

Human Microbiome Market Companies

The competitive landscape of the human microbiome industry includes 4D Pharma plc.

  • Synlogic
  • Microbiome Therapeutics LLC
  • Enterome
  • Metabiomics Corporation
  • Seres Therapeutics
  • Second Genome Inc.
  • Vedanta Biosciences, Inc.
  • Synthetic Biologics, Inc.
  • DuPont
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are some of the prominent players in the human microbiome industry?
Key players in the industry include 4D Pharma plc, Synlogic, Microbiome Therapeutics LLC, Enterome, Metabiomics Corporation, Seres Therapeutics, Second Genome Inc., Vedanta Biosciences, Inc., Synthetic Biologics, Inc., and DuPont.
How much is the North America human microbiome industry worth?
Why is the digestive tract segment leading the market?
How big is the human microbiome market?

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing burden of lifestyle-related diseases and the growing geriatric population

3.2.1.2    Increasing funding initiatives and government program

3.2.1.3    Increasing demand precision medicine

3.2.1.4    Long regulatory pathways and high development costs

3.2.2    Industry pitfalls & challenges

3.2.2.1    Ethical and safety concern

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technological landscape

3.5.1    Core technologies

3.5.2    Adjacent technologies

3.6    Future market trends

3.7    Porter’s analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Human Microbiome Market, By Site, 2018 - 2032 (USD Million)

5.1    Key trends

5.2    Digestive tract

5.3    Lung

5.4    Reproductive cavity

5.5    Skin

5.6    Other sites

Chapter 6   Human Microbiome Market, By Application, 2018 – 2032 (USD Million)

6.1    Key trends

6.2    Therapeutics

6.3    Diagnostics

Chapter 7   Human Microbiome Market, By Disease, 2018 – 2032 (USD Million)

7.1    Key trends

7.2    Infectious diseases

7.3    Gastrointestinal diseases

7.4    Endocrine & metabolic diseases

7.5    Cancer

7.6    Central nervous system disorder

7.7    Other diseases

Chapter 8   Human Microbiome Market, By Product, 2018 – 2032 (USD Million)

8.1    Key trends

8.2    Drugs

8.3    Probiotics

8.4    Prebiotics

8.5    Diagnostic tests

8.6    Other products

Chapter 9   Human Microbiome Market, By Region, 2018 – 2032 (USD Million)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.6    MEA

9.6.1    South Africa

9.6.2    Saudi Arabia

Chapter 10   Company Profiles

10.1    Seres Therapeutics

10.2    Enterome

10.3    Second Genome Inc.

10.4    DuPont

10.5    Synthetic Biologics, Inc.

10.6    Synlogic

10.7    Vedanta Biosciences, Inc.

10.8    Metabiomics Corporation

10.9    MICROBIOME THERAPEUTICS LLC

10.10    4D pharma plc

Authors: Mariam Faizullabhoy, Gauri Wani
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2023

Companies covered: 10

Tables & Figures: 269

Countries covered: 15

Pages: 180

Download Free Sample

Top